478 related articles for article (PubMed ID: 19229247)
1. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.
Uhl M; Kepp O; Jusforgues-Saklani H; Vicencio JM; Kroemer G; Albert ML
Cell Death Differ; 2009 Jul; 16(7):991-1005. PubMed ID: 19229247
[TBL] [Abstract][Full Text] [Related]
2. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
[TBL] [Abstract][Full Text] [Related]
3. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells.
Oh DS; Lee HK
Autophagy; 2019 Dec; 15(12):2091-2106. PubMed ID: 30900506
[TBL] [Abstract][Full Text] [Related]
4. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
Le Bon A; Etchart N; Rossmann C; Ashton M; Hou S; Gewert D; Borrow P; Tough DF
Nat Immunol; 2003 Oct; 4(10):1009-15. PubMed ID: 14502286
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8
Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700
[TBL] [Abstract][Full Text] [Related]
6. Survival of effector CD8+ T cells during influenza infection is dependent on autophagy.
Schlie K; Westerback A; DeVorkin L; Hughson LR; Brandon JM; MacPherson S; Gadawski I; Townsend KN; Poon VI; Elrick MA; Côté HC; Abraham N; Wherry EJ; Mizushima N; Lum JJ
J Immunol; 2015 May; 194(9):4277-86. PubMed ID: 25833396
[TBL] [Abstract][Full Text] [Related]
7. Autophagy regulates long-term cross-presentation by murine dendritic cells.
Ho NI; Camps MGM; Verdoes M; Münz C; Ossendorp F
Eur J Immunol; 2021 Apr; 51(4):835-847. PubMed ID: 33349928
[TBL] [Abstract][Full Text] [Related]
8. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
[TBL] [Abstract][Full Text] [Related]
9. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
Lorenzi S; Mattei F; Sistigu A; Bracci L; Spadaro F; Sanchez M; Spada M; Belardelli F; Gabriele L; Schiavoni G
J Immunol; 2011 May; 186(9):5142-50. PubMed ID: 21441457
[TBL] [Abstract][Full Text] [Related]
10. TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming.
Barbet G; Nair-Gupta P; Schotsaert M; Yeung ST; Moretti J; Seyffer F; Metreveli G; Gardner T; Choi A; Tortorella D; Tampé R; Khanna KM; García-Sastre A; Blander JM
Nat Immunol; 2021 Apr; 22(4):497-509. PubMed ID: 33790474
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
[TBL] [Abstract][Full Text] [Related]
12. Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments.
Kang TH; Lee JH; Noh KH; Han HD; Shin BC; Choi EY; Peng S; Hung CF; Wu TC; Kim TW
Int J Cancer; 2007 Apr; 120(8):1696-703. PubMed ID: 17230516
[TBL] [Abstract][Full Text] [Related]
13. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
[TBL] [Abstract][Full Text] [Related]
14. Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8(+) T Cell Responses.
Loi M; Müller A; Steinbach K; Niven J; Barreira da Silva R; Paul P; Ligeon LA; Caruso A; Albrecht RA; Becker AC; Annaheim N; Nowag H; Dengjel J; García-Sastre A; Merkler D; Münz C; Gannagé M
Cell Rep; 2016 May; 15(5):1076-1087. PubMed ID: 27117419
[TBL] [Abstract][Full Text] [Related]
15. MHC Class I Internalization via Autophagy Proteins.
Loi M; Ligeon LA; Münz C
Methods Mol Biol; 2019; 1880():455-477. PubMed ID: 30610715
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life.
Peng S; Kim TW; Lee JH; Yang M; He L; Hung CF; Wu TC
Hum Gene Ther; 2005 May; 16(5):584-93. PubMed ID: 15916483
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α
Parekh VV; Pabbisetty SK; Wu L; Sebzda E; Martinez J; Zhang J; Van Kaer L
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6371-E6380. PubMed ID: 28716903
[TBL] [Abstract][Full Text] [Related]
18. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 3 promotes cross-priming to virus-infected cells.
Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C
Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573
[TBL] [Abstract][Full Text] [Related]
20. Effective Priming of Herpes Simplex Virus-Specific CD8
Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
